Preventing the Rise in Blood Pressure With Age Using Reduced-sodium Salt
NCT ID: NCT05912426
Last Updated: 2024-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
148 participants
INTERVENTIONAL
2024-03-05
2024-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sodium-Potassium Blood Pressure Trial in Children
NCT00000521
Salt Reduction on Blood Pressure and Cardiovascular Organ Damage
NCT00152074
The Effects on Blood Pressure of Salt Substitute Among Adults With Hypertension in India
NCT03909659
Potassium and Sodium to Control Blood Pressure in Hypertensives
NCT00000509
Low Sodium Cooking Study
NCT03481322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reduced-sodium potassium-enriched salt
Reduced-sodium potassium-enriched salt
Reduced-sodium potassium-enriched salt
Supply and use of a reduced-sodium, potassium-enriched iodised salt (66% potassium chloride, 34% sodium chloride).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reduced-sodium potassium-enriched salt
Supply and use of a reduced-sodium, potassium-enriched iodised salt (66% potassium chloride, 34% sodium chloride).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All household members consume greater than half of meals as food prepared in the home (self-report)
* All household members provide signed informed consent/assent (consent obtained from legal guardians for those \<18 years of age; assent also obtained from children/adolescents ≥12 years of age)
Exclusion Criteria
* Any household member uses a potassium-sparing diuretic.
* Any household member uses a potassium supplement.
* Any household member has other reason for concern about the use of reduced-sodium salt.
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Abuja Teaching Hospital
OTHER
The George Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katrina Kissock, PhD
Role: STUDY_CHAIR
The George Institute
Bruce Neal, PhD
Role: PRINCIPAL_INVESTIGATOR
The George Institute
Dike Ojji, PhD
Role: STUDY_DIRECTOR
University of Abuja Teaching Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gofidna
Abuja Municipal Area Council, Federal Capital Territory, Nigeria
Jahi-2
Abuja Municipal Area Council, Federal Capital Territory, Nigeria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kissock KR, Okoro C, Trieu K, Ripiye NR, Orji A, Huffman MD, Neal B, Ojji D. A feasibility study for a trial testing the effects of reduced-sodium salt on the rise in blood pressure with age. Nutr Metab Cardiovasc Dis. 2025 Oct;35(10):104129. doi: 10.1016/j.numecd.2025.104129. Epub 2025 May 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UATH/HREC/PR/2023/06/084
Identifier Type: OTHER
Identifier Source: secondary_id
HC230273
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.